Search Results

There are 11645 results for: content related to: Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Article first published online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. You have free access to this content
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 844–853, Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

    Article first published online : 27 DEC 2007, DOI: 10.1002/hep.22106

  3. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  4. You have free access to this content
    Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection

    Alimentary Pharmacology & Therapeutics

    Volume 24, Issue 7, October 2006, Pages: 1003–1016, H. E. KOHRT, D. L. OUYANG and E. B. KEEFFE

    Article first published online : 12 SEP 2006, DOI: 10.1111/j.1365-2036.2006.03081.x

  5. Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy

    Journal of Medical Virology

    Volume 59, Issue 3, November 1999, Pages: 263–269, Winnie Yeo, Joyce L. Steinberg, John S. Tam, Paul K.S. Chan, Nancy W.Y. Leung, Kwok C. Lam, Tony S.K. Mok and Philip J. Johnson

    Article first published online : 27 SEP 1999, DOI: 10.1002/(SICI)1096-9071(199911)59:3<263::AID-JMV1>3.0.CO;2-X

  6. Hepatitis B-related serological events in hematopoietic stem cell transplant patients and efficacy of lamivudine prophylaxis against reactivation

    Hematological Oncology

    Alok Gupta, Sachin Punatar, Jayant Gawande, Bhausaheb Bagal, Libin Mathew, Vivek Bhat, Sadhana Kannan and Navin Khattry

    Article first published online : 18 FEB 2015, DOI: 10.1002/hon.2195

  7. Hepatitis B reactivation in allogeneic hemopoietic stem cell transplantation setting: A pediatric experience

    Pediatric Transplantation

    Volume 13, Issue 7, November 2009, Pages: 923–926, M. Faraci, B. Cappelli, E. Lanino, G. Morreale, F. Fioredda, C. L. Giudice and R. Giacchino

    Article first published online : 19 NOV 2008, DOI: 10.1111/j.1399-3046.2008.01080.x

  8. You have free access to this content
    Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 864–871, John S Lubel and Peter W Angus

    Article first published online : 28 APR 2010, DOI: 10.1111/j.1440-1746.2010.06243.x

  9. Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers

    Transplant Infectious Disease

    Volume 15, Issue 3, June 2013, Pages: 300–305, G.-D. Chen, J.-L. Gu, J. Qiu and L.-Z. Chen

    Article first published online : 8 MAR 2013, DOI: 10.1111/tid.12065

  10. Hepatitis B virus reactivation associated with anti-neoplastic therapy

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 1, January 2013, Pages: 31–37, Winnie Yeo and Henry LY Chan

    Article first published online : 19 DEC 2012, DOI: 10.1111/j.1440-1746.2012.07280.x

  11. Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis

    Liver International

    Volume 28, Issue 1, January 2008, Pages: 28–38, Lenna A. Martyak, Ehsan Taqavi and Sammy Saab

    Article first published online : 1 NOV 2007, DOI: 10.1111/j.1478-3231.2007.01618.x

  12. Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy

    Hepatology Research

    Volume 42, Issue 7, July 2012, Pages: 627–636, Makoto Oketani, Akio Ido, Hirofumi Uto and Hirohito Tsubouchi

    Article first published online : 12 JUN 2012, DOI: 10.1111/j.1872-034X.2012.00998.x

  13. You have free access to this content
    Abstracts 890 to 1096

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 632A–724A,

    Article first published online : 19 SEP 2007, DOI: 10.1002/hep.22020

  14. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

    Journal of Viral Hepatitis

    Volume 11, Issue 2, March 2004, Pages: 141–147, R. Idilman, M. Arat, E. Soydan, M. Törüner, İ. Soykan, H. Akbulut, Ö. Arslan, M. Özcan, A. R. Türkyilmaz, M. Bozdayı, S. Karayalçın, D. H. Van Thiel, A. Özden, M. Beksaç and H. Akan

    Article first published online : 20 FEB 2004, DOI: 10.1046/j.1365-2893.2003.00479.x

  15. Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration

    Liver International

    Volume 24, Issue 6, December 2004, Pages: 540–546, M. S. Dai, P. F. Wu, R. Y. Shyu, J. J. Lu and T. Y. Chao

    Article first published online : 26 NOV 2004, DOI: 10.1111/j.1478-3231.2004.0964.x

  16. You have free access to this content
    A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization

    Hepatology

    Volume 43, Issue 2, February 2006, Pages: 233–240, Jeong Won Jang, Jong Young Choi, Si Hyun Bae, Seung Kew Yoon, U Im Chang, Chang Wook Kim, Se Hyun Cho, Jun Yeol Han and Young Sok Lee

    Article first published online : 26 JAN 2006, DOI: 10.1002/hep.21024

  17. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease

    Liver International

    Volume 33, Issue 8, September 2013, Pages: 1203–1210, Fei W. Chen, Luke Coyle, Brett E. Jones and Venessa Pattullo

    Article first published online : 24 MAR 2013, DOI: 10.1111/liv.12154

  18. You have free access to this content
    Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy

    British Journal of Haematology

    Volume 115, Issue 1, October 2001, Pages: 58–62, Giuseppe Rossi, Annamaria Pelizzari, Maddalena Motta and Massimo Puoti

    Article first published online : 20 DEC 2001, DOI: 10.1046/j.1365-2141.2001.03099.x

  19. You have free access to this content
    Beneficial Effects of Short-Term Lamivudine Treatment for de novo Hepatitis B Virus Reactivation After Liver Transplantation

    American Journal of Transplantation

    Volume 6, Issue 11, November 2006, Pages: 2680–2685, M. Umeda, H. Marusawa, M. Ueda, Y. Takada, H. Egawa, S. Uemoto and T. Chiba

    Article first published online : 16 OCT 2006, DOI: 10.1111/j.1600-6143.2006.01542.x

  20. Role of lamivudine with transarterial chemoembolization in the survival of patients with hepatocellular carcinoma

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 6, June 2014, Pages: 1273–1278, Xiaojing Xu, Peixin Huang, Hui Tian, Yi Chen, Ningling Ge, Wengquing Tang, Biwei Yang and Jinglin Xia

    Article first published online : 15 MAY 2014, DOI: 10.1111/jgh.12554

    Corrected by:

    Erratum: Erratum

    Vol. 29, Issue 10, 1848, Article first published online: 15 OCT 2014